Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

16.85 +0.09 (+0.54%)
Streaming Delayed Price Updated: 12:18 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Seres Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study Progress
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. iQIYI, Inc. (NASDAQ: IQ) shares dipped 14.1% to $3.31 in... 
Via Benzinga
News headline image
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket ↗
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio. 
Via Benzinga
News headline image
Recap: Seres Therapeutics Q3 Earnings ↗
Seres Therapeutics (NASDAQ:MCRB) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Seres Therapeutics to Host Investor Webcast on December 8, 2022 to Discuss SER-109 Commercial Strategy
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics to Host Third Quarter 2022 Financial Results and Operational Progress Conference Call and Webcast on November 2, 2022
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Recap: Seres Therapeutics Q2 Earnings ↗
  Seres Therapeutics (NASDAQ:MCRB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics Presents SER-109 ECOSPOR IV Study Data at IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meetings
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics’ ECOSPOR III Study Data on SER-109 Published in Journal of the American Medical Association
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics to Present Clinical Results at IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meeting
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
News headline image
Ford, Evotec And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. 
Via Benzinga
News headline image
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Seres Therapeutics to Present at World Anti-Microbial Resistance Congress
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. 
Via Benzinga
News headline image
Why Seres Therapeutics Shares Are Popping Off Today ↗
Seres Therapeutics Inc (NASDAQ: MCRB) shares are trading higher by 13.24% to $6.12 Wednesday morning after the company announced it completed the rolling submission process for its BLA to the FDA for... 
Via Benzinga
News headline image
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday ↗
  
Via Benzinga
News headline image
Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
  
Via Benzinga
News headline image
Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Seres Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates
From Seres Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.